The U.S. will begin sharing its entire pipeline of vaccines from AstraZeneca once the COVID-19 vaccine meets federal safety requirements, White House press secretary Jen Psaki said Monday.
Speaking to reporters on Monday, she said as many as 60 million doses are expected to become available for export within the next two months.
The move greatly expands on the Biden administration’s action last month to share about 4 million doses of the vaccine with Canada and Mexico.
However, the number of AstraZeneca doses each country will now be allotted is unclear, as is the expected delivery date.
The AstraZeneca vaccine is widely in use around the world but not yet authorized by the U.S. Food and Drug Administration.